Loading insider details...
Latest Form 4 (Apr 20, 2026): Grant/Award of 60,000 KLRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 20, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 60,000 | n/a |
| Nov 1, 2023 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 9,418 | n/a |
| Feb 7, 2023 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 47,500 | n/a |
| Jul 6, 2022 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 31,746 | $100.0K |
| Feb 9, 2022 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 190,000 | n/a |